NIH offers access to biospecimens from brain development and tobacco and health studies for research on genetic and environmental factors affecting lifelong health and disease.
This limited competition funds continued operation of National Cancer Institute biospecimen banks supporting national, early-phase, and experimental cancer clinical trials and translational research.
Supporting innovative and novel research to measure brain changes over longer periods, impacting neurodevelopment, aging, and disease risk in both humans and animals across all ages.
Encouraging innovative approaches to measure brain changes across lifespan for improved understanding of neurodevelopment and aging.
The NIDA Animal Genomics Program aims to identify genetic variants influencing addictive behaviors, SUD stages, associated behaviors, and comorbidities through genomics approaches.
NIH offers access to All of Us blood plasma, serum, and DNA for externally funded partnered studies that advance precision medicine and add data for broad research use; clinical trials are not allowed.